Rankings
▼
Calendar
INVA Q3 2016 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
Gross Profit
$33M
99.1% margin
Operating Income
$28M
83.8% margin
Net Income
$15M
45.1% margin
EPS (Diluted)
$0.13
QoQ Revenue Growth
+2.6%
Cash Flow
Operating Cash Flow
$20M
Free Cash Flow
$20M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$371M
Total Liabilities
$738M
Stockholders' Equity
-$368M
Cash & Equivalents
$93M
← FY 2016
All Quarters
Q4 2016 →